Women Who Are Young, Non-White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed-Effects Regression Analysis
- PMID: 33000504
- PMCID: PMC7794185
- DOI: 10.1002/onco.13544
Women Who Are Young, Non-White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed-Effects Regression Analysis
Abstract
Purpose: We examined self-reported financial toxicity and out-of-pocket expenses among adult women with breast cancer.
Methods: Patients spoke English, Spanish, or Mandarin Chinese, were aged 18+ years, had stage I-IIIA breast cancer, and were eligible for breast-conserving and mastectomy surgery. Participants completed surveys about out-of-pocket costs and financial toxicity at 1 week, 12 weeks, and 1 year postsurgery.
Results: Three hundred ninety-five of 448 eligible patients (88.2%) from the parent trial completed surveys. Excluding those reporting zero costs, crude mean ± SD out-of-pocket costs were $1,512 ± $2,074 at 1 week, $2,609 ± $6,369 at 12 weeks, and $3,308 ± $5,000 at 1 year postsurgery. Controlling for surgery, cancer stage, and demographics with surgeon and clinic as random effects, higher out-of-pocket costs were associated with higher financial toxicity 1 week and 12 weeks postsurgery (p < .001). Lower socioeconomic status (SES) was associated with lower out-of-pocket costs at each time point (p = .002-.013). One week postsurgery, participants with lower SES reported financial toxicity scores 1.02 points higher than participants with higher SES (95% confidence interval [CI], 0.08-1.95). Black and non-White/non-Black participants reported financial toxicity scores 1.91 (95% CI, 0.46-3.37) and 2.55 (95% CI, 1.11-3.99) points higher than White participants. Older (65+ years) participants reported financial toxicity scores 2.58 points lower than younger (<65 years) participants (95% CI, -3.41, -1.74). Younger participants reported significantly higher financial toxicity at each time point.
Discussion: Younger age, non-White race, and lower SES were associated with higher financial toxicity regardless of costs. Out-of-pocket costs increased over time and were positively associated with financial toxicity. Future work should reduce the impact of cancer care costs among vulnerable groups.
Implications for practice: This study was one of the first to examine out-of-pocket costs and financial toxicity up to 1 year after breast cancer surgery. Younger age, Black race, race other than Black or White, and lower socioeconomic status were associated with higher financial toxicity. Findings highlight the importance of addressing patients' financial toxicity in several ways, particularly for groups vulnerable to its effects.
Keywords: Breast cancer; Costs of care; Financial toxicity.
© 2020 The Authors. The Oncologist published by Wiley Periodicals LLC on behalf of AlphaMed Press.
Conflict of interest statement
Figures

Similar articles
-
Financial Toxicity in Breast Reconstruction: A National Survey of Women Who have Undergone Breast Reconstruction After Mastectomy.Ann Surg Oncol. 2022 Jan;29(1):535-544. doi: 10.1245/s10434-021-10708-5. Epub 2021 Sep 3. Ann Surg Oncol. 2022. PMID: 34480284
-
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.Oncologist. 2021 Jul;26(7):588-596. doi: 10.1002/onco.13767. Epub 2021 Apr 21. Oncologist. 2021. PMID: 33783054 Free PMC article. Clinical Trial.
-
What matters most: protocol for a randomized controlled trial of breast cancer surgery encounter decision aids across socioeconomic strata.BMC Public Health. 2018 Feb 13;18(1):241. doi: 10.1186/s12889-018-5109-2. BMC Public Health. 2018. PMID: 29439691 Free PMC article. Clinical Trial.
-
Financial Toxicity in Breast Reconstruction: The Role of the Surgeon-Patient Cost-of-Care Discussion.Semin Plast Surg. 2024 Jan 19;38(1):39-47. doi: 10.1055/s-0043-1778040. eCollection 2024 Feb. Semin Plast Surg. 2024. PMID: 38495060 Free PMC article. Review.
-
Financial Toxicity and Breast Cancer: Why Does It Matter, Who Is at Risk, and How Do We Intervene?Am Soc Clin Oncol Educ Book. 2025 Jun;45(3):e473450. doi: 10.1200/EDBK-25-473450. Epub 2025 May 2. Am Soc Clin Oncol Educ Book. 2025. PMID: 40315376 Review.
Cited by
-
Individualized Out-of-Pocket Price Estimators for "Shoppable" Surgical Procedures: A Nationwide Cross-Sectional Study of US Hospitals.Ann Surg Open. 2022 May 3;3(2):e162. doi: 10.1097/AS9.0000000000000162. eCollection 2022 Jun. Ann Surg Open. 2022. PMID: 36936723 Free PMC article.
-
Greater financial toxicity correlates with increased psychological distress and lower quality of life among Turkish cancer patients.Support Care Cancer. 2023 Jan 26;31(2):137. doi: 10.1007/s00520-023-07586-w. Support Care Cancer. 2023. PMID: 36700998
-
Cancer cost-related subjective financial distress among breast cancer: a scoping review.Support Care Cancer. 2024 Jul 3;32(7):484. doi: 10.1007/s00520-024-08698-7. Support Care Cancer. 2024. PMID: 38958768
-
Identifying missing links in the conceptualization of financial toxicity: a qualitative study.Support Care Cancer. 2022 Mar;30(3):2273-2282. doi: 10.1007/s00520-021-06643-6. Epub 2021 Oct 30. Support Care Cancer. 2022. PMID: 34716793 Free PMC article.
-
Impact of age and treatment-related adverse events on financial toxicity among patients with breast cancer: a systematic review.J Cancer Surviv. 2025 Aug 30. doi: 10.1007/s11764-025-01881-7. Online ahead of print. J Cancer Surviv. 2025. PMID: 40884698
References
-
- Azzani M, Roslani AC, Su TT. The perceived cancer‐related financial hardship among patients and their families: A systematic review. Support Care Cancer 2015;23:889–898. - PubMed
-
- McGuire A, Drummond M, Martin M et al. End of life or end of the road? Are rising cancer costs sustainable? Is it time to consider alternative incentive and funding schemes? Expert Rev Pharmacoecon Outcomes Res 2015;15:599–605. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical